S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
NASDAQ:LQDA

Liquidia Stock Forecast, Price & News

$5.50
-0.25 (-4.35%)
(As of 01/21/2022 04:00 PM ET)
Add
Compare
Today's Range
$5.45
$5.79
50-Day Range
$3.82
$6.81
52-Week Range
$2.25
$7.16
Volume
344,194 shs
Average Volume
1.00 million shs
Market Capitalization
$285.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.26
30 days | 90 days | 365 days | Advanced Chart
Receive LQDA News and Ratings via Email

Sign-up to receive the latest news and ratings for Liquidia and its competitors with MarketBeat's FREE daily newsletter.


Liquidia logo

About Liquidia

Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. The company was founded on June 28, 2020 and is headquartered in Morrisville, NC.

Headlines

Liquidia And United: The Tango Continues - Seeking Alpha
January 18, 2022 |  seekingalpha.com
Liquidia (NASDAQ:LQDA) PT Raised to $12.00 at Needham & Company LLC
January 10, 2022 |  americanbankingnews.com
Liquidia (NASDAQ:LQDA) Earns Hold Rating from Wedbush
January 7, 2022 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LQDA
Fax
N/A
Employees
51
Year Founded
N/A

Sales & Book Value

Annual Sales
$740 thousand

Profitability

Net Income
$-59.76 million
Net Margins
-376.75%
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
36,644,000
Market Cap
$285.88 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/03/2021
Today
1/23/2022
Next Earnings (Estimated)
3/22/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.21 out of 5 stars

Medical Sector

378th out of 1,419 stocks

Surgical & Medical Instruments Industry

45th out of 130 stocks

Analyst Opinion: 3.3Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.0 5 -4 -3 -2 -1 -












Liquidia (NASDAQ:LQDA) Frequently Asked Questions

Is Liquidia a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Liquidia in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Liquidia stock.
View analyst ratings for Liquidia
or view top-rated stocks.

How has Liquidia's stock been impacted by COVID-19 (Coronavirus)?

Liquidia's stock was trading at $3.66 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, LQDA shares have increased by 50.3% and is now trading at $5.50.
View which stocks have been most impacted by COVID-19
.

When is Liquidia's next earnings date?

Liquidia is scheduled to release its next quarterly earnings announcement on Tuesday, March 22nd 2022.
View our earnings forecast for Liquidia
.

How were Liquidia's earnings last quarter?

Liquidia Co. (NASDAQ:LQDA) announced its earnings results on Wednesday, November, 3rd. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by $0.02. The company earned $3.18 million during the quarter, compared to the consensus estimate of $2.48 million. Liquidia had a negative net margin of 376.75% and a negative trailing twelve-month return on equity of 71.68%.
View Liquidia's earnings history
.

What price target have analysts set for LQDA?

3 equities research analysts have issued 12-month price targets for Liquidia's shares. Their forecasts range from $6.00 to $12.00. On average, they anticipate Liquidia's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 45.5% from the stock's current price.
View analysts' price targets for Liquidia
or view top-rated stocks among Wall Street analysts.

Who are Liquidia's key executives?

Liquidia's management team includes the following people:
  • Damian deGoa, Chief Executive Officer & Director
  • Robert A. Lippe, Chief Operating Officer
  • Michael Kaseta, Chief Financial Officer
  • Tushar Shah, Chief Medical Officer
  • Scott Moomaw, Senior Vice President-Commercial

What other stocks do shareholders of Liquidia own?

When did Liquidia IPO?

(LQDA) raised $50 million in an initial public offering (IPO) on Thursday, July 26th 2018. The company issued 4,500,000 shares at a price of $10.00-$12.00 per share. Jefferies and Cowen served as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers.

What is Liquidia's stock symbol?

Liquidia trades on the NASDAQ under the ticker symbol "LQDA."

How do I buy shares of Liquidia?

Shares of LQDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Liquidia's stock price today?

One share of LQDA stock can currently be purchased for approximately $5.50.

How much money does Liquidia make?

Liquidia has a market capitalization of $285.88 million and generates $740 thousand in revenue each year. The company earns $-59.76 million in net income (profit) each year or ($0.86) on an earnings per share basis.

How many employees does Liquidia have?

Liquidia employs 51 workers across the globe.

What is Liquidia's official website?

The official website for Liquidia is www.liquidia.com.

Where are Liquidia's headquarters?

Liquidia is headquartered at 419 DAVIS DRIVE SUITE 100, MORRISVILLE NC, 27560.

How can I contact Liquidia?

Liquidia's mailing address is 419 DAVIS DRIVE SUITE 100, MORRISVILLE NC, 27560. The company can be reached via phone at (919) 328-4400 or via email at [email protected].


This page was last updated on 1/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.